UB Paderborn / Katalog / Suche / in CDI

Mutations in SERPINF1 cause osteogenesis imperfecta type VI

Journal of bone and mineral research, 2011-12, Vol.26 (12), p.2798-2803

2011

Volltextzugriff (PDF)

Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

Journal of bone and mineral research, 2000-09, Vol.15 (9), p.1650-1658

2000

Volltextzugriff (PDF)

Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism

The journal of clinical endocrinology and metabolism, 2003-03, Vol.88 (3), p.986-992

2003

Volltextzugriff (PDF)

Cellular Activity on the Seven Surfaces of Iliac Bone: A Histomorphometric Study in Children and Adolescents

Journal of bone and mineral research, 2006-04, Vol.21 (4), p.513-519

2006

Volltextzugriff (PDF)

Deficient Bone Formation in Idiopathic Juvenile Osteoporosis: A Histomorphometric Study of Cancellous Iliac Bone

Journal of bone and mineral research, 2000-05, Vol.15 (5), p.957-963

2000

Volltextzugriff (PDF)

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

The Journal of clinical investigation, 2002-11, Vol.110 (9), p.1293-1299

2002

Volltextzugriff (PDF)

Pamidronate in Children with Osteogenesis Imperfecta: Histomorphometric Effects of Long-Term Therapy

The journal of clinical endocrinology and metabolism, 2006-02, Vol.91 (2), p.511-516

2006

Volltextzugriff (PDF)

Intracortical remodeling during human bone development—A histomorphometric study

Bone (New York, N.Y.), 2007-02, Vol.40 (2), p.274-280

2007

Volltextzugriff (PDF)

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

The New England journal of medicine, 1998-10, Vol.339 (14), p.947-952

1998

Volltextzugriff (PDF)

Osteogenesis imperfecta type VI in childhood and adolescence: Effects of cyclical intravenous pamidronate treatment

Bone (New York, N.Y.), 2007-03, Vol.40 (3), p.638-644

2007

Volltextzugriff (PDF)

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4569-4575

2003

Volltextzugriff (PDF)

Effects of Intravenous Pamidronate Treatment in Infants With Osteogenesis Imperfecta: Clinical and Histomorphometric Outcome

Journal of bone and mineral research, 2005-07, Vol.20 (7), p.1235-1243

2005

Volltextzugriff (PDF)

Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect

Journal of bone and mineral research, 2002-01, Vol.17 (1), p.30-38

2002

Volltextzugriff (PDF)

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

The journal of clinical endocrinology and metabolism, 2000-05, Vol.85 (5), p.1846-1850

2000

Volltextzugriff (PDF)

Deficient Mineralization of Intramembranous Bone in Vitamin D-24-Hydroxylase-Ablated Mice Is Due to Elevated 1,25-Dihydroxyvitamin D and Not to the Absence of 24,25-Dihydroxyvitamin D

Endocrinology (Philadelphia), 2000-07, Vol.141 (7), p.2658-2666

2000

Volltextzugriff (PDF)

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V

Bone (New York, N.Y.), 2006, Vol.38 (1), p.13-20

2006

Volltextzugriff (PDF)

Sclerotic Metaphyseal Lines in a Child Treated With Pamidronate: Histomorphometric Analysis

Journal of bone and mineral research, 2004-07, Vol.19 (7), p.1191-1193

2004

Volltextzugriff (PDF)

Bone Mineralization in Polyostotic Fibrous Dysplasia: Histomorphometric Analysis

Journal of bone and mineral research, 2002-11, Vol.17 (11), p.1949-1953

2002

Volltextzugriff (PDF)

Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder?

Bone (New York, N.Y.), 2004-11, Vol.35 (5), p.1023-1028

2004

Volltextzugriff (PDF)

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

The Journal of clinical investigation, 2002-11, Vol.110 (9), p.1293-1299

2002

Volltextzugriff (PDF)

Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age

Pediatrics (Evanston), 2002-07, Vol.110 (1 Pt 1), p.105

2002

Volltextzugriff (PDF)

Influence of magnesium supplementation on bone turnover in the normal young mouse

Calcified tissue international, 1983-12, Vol.35 (1), p.755-761

1983

Volltextzugriff (PDF)

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets

The journal of clinical endocrinology and metabolism, 1992-09, Vol.75 (3), p.879-885

1992

Volltextzugriff (PDF)

Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse

Calcified tissue international, 1982-12, Vol.34 (2), p.158-164

1982

Volltextzugriff (PDF)

24,25 dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets : A clinical research center study

The journal of clinical endocrinology and metabolism, 1996-06, Vol.81 (6), p.2381-2388

1996

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mutations in SERPINF1 cause osteogenesis imperfecta type VI

Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism

Cellular Activity on the Seven Surfaces of Iliac Bone: A Histomorphometric Study in Children and Adolescents

Deficient Bone Formation in Idiopathic Juvenile Osteoporosis: A Histomorphometric Study of Cancellous Iliac Bone

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

Pamidronate in Children with Osteogenesis Imperfecta: Histomorphometric Effects of Long-Term Therapy

Intracortical remodeling during human bone development—A histomorphometric study

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

Osteogenesis imperfecta type VI in childhood and adolescence: Effects of cyclical intravenous pamidronate treatment

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

Effects of Intravenous Pamidronate Treatment in Infants With Osteogenesis Imperfecta: Clinical and Histomorphometric Outcome

Osteogenesis Imperfecta Type VI: A Form of Brittle Bone Disease with a Mineralization Defect

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

Deficient Mineralization of Intramembranous Bone in Vitamin D-24-Hydroxylase-Ablated Mice Is Due to Elevated 1,25-Dihydroxyvitamin D and Not to the Absence of 24,25-Dihydroxyvitamin D

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V

Sclerotic Metaphyseal Lines in a Child Treated With Pamidronate: Histomorphometric Analysis

Bone Mineralization in Polyostotic Fibrous Dysplasia: Histomorphometric Analysis

Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder?

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age

Influence of magnesium supplementation on bone turnover in the normal young mouse

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets

Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse

24,25 dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets : A clinical research center study

Suchergebnisse filtern